Leucocare AG Martinsried/München News & Veranstaltungen

Press Releases

Sep. 2017

 LEUKOCARE continues to expand and invests in research and development

Feb. 2017

Rentschler and Leukocare announce strategic alliance and equity investment

Sep. 2016

LEUKOCARE grants license to US vaccine company PaxVax 

Jul. 2016

Dr. Andreas Rummelt, pharma industry expert and former CEO of Sandoz, was elected as new supervisory board member at LEUKOCARE’s annual shareholder meeting on July 12th.





2014 December, PLoS ONE 9(12): e115940. doi:10.1371/journal.pone.

WINDOLF C.D. ET AL.:Lysostaphin-Coated Titan-Implants Preventing Localized Osteitis by Staphyloccus aureus in a Mouse Model (more...)

Human Vaccines & Immunotherapeutics

2014 July; Vol. 10, Issue 10, Meeting Report

DERWAND R.: Annual World Vaccine Congress 2014: A re-evaluation of the value proposition for increasing vaccine thermostability (more...)


2014 April; Vol. 32, Issue 19

SCHERLIESS R. ET AL.: Induction of protective immunity against H1N1 influenza A(H1N1)pdm09 with spray-dried and electron-beam sterilised vaccines in non-human primates


Materials Today

2012 September; Vol. 15, Number 9

TSCHELIESSNIG R. ET AL.: Nano-coating protects biofunctional materials



Next Events

Meet us at the following events

BIO-EUROPE Spring 2018

BIO-EUROPE Spring 2018
March 12th - March 14th, 2018
Amsterdam, The Netherlands (more...)